Surveillance for hepatocellular carcinoma: It is time to move forward

키워드

참고문헌 (32)

1. Sung H, "Global cancer statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185countries", CA Cancer J Clin, 71, pp.209~249 (2021)
2. Young Eun Chon, "Hepatocellular carcinoma statistics in South Korea", Clinical and Molecular Hepatology, 27(3), pp.512~514 (2021), 대한간학회[DOI]
3. European Association for the Study of the Liver, "EASL clinical practice guidelines : management of hepatocellular carcinoma", J Hepatol, 69, pp.182~236 (2018)
4. Jun Sik Yoon, "Hepatocellular Carcinoma in Korea Between 2008 and 2011: an Analysis of Korean Nationwide Cancer Registry", Journal of Liver Cancer, 20(1), pp.41~52 (2020), 대한간암학회[DOI]
5. 전영은, "Hepatocellular Carcinoma in Korea between 2012 and 2014: an Analysis of Data from the Korean Nationwide Cancer Registry", Journal of Liver Cancer, 20(2), pp.135~147 (2020), 대한간암학회[DOI]
6. Jun Sik Yoon, "Hepatocellular Carcinoma in Korea: an Analysis of the 2015 Korean Nationwide Cancer Registry", Journal of Liver Cancer, 21(1), pp.58~68 (2021), 대한간암학회[DOI]
7. Marrero JA, "Diagnosis, staging, and management of hepatocellular carcinoma : 2018 practice guidance by the American Association for the Study of Liver Diseases", Hepatology, 68, pp.723~750 (2018)
8. Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC, "2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma", Gut and Liver, 13(3), pp.227~299 (2019), 거트앤리버 소화기연관학회협의회[DOI]
9. Kokudo N, "Clinical practice guidelines for hepatocellular carcinoma : the Japan Society of Hepatology 2017(4th JSH-HCC guidelines)2019 update", Hepatol Res, 49, pp.1109~1113 (2019)
10. Choi SI, "Better survival of patients with hepatitis B virus-related hepatocellular carcinoma in South Korea : changes in 16-years cohorts", PLoS One, 17, pp.e0265668~ (2022)
11. Sherman M, "Surveillance for hepatocellular carcinoma", Best Pract Res Clin Gastroenterol, 28, pp.783~793 (2014)
12. Zhang BH, "Randomized controlled trial of screening for hepatocellular carcinoma", J Cancer Res Clin Oncol, 130, pp.417~422 (2004)
13. Chen JG, "Screening for liver cancer : results of a randomised controlled trial in Qidong, China", J Med Screen, 10, pp.204~209 (2003)
14. Jepsen P, "We need stronger evidence for(or against)hepatocellular carcinoma surveillance", J Hepatol, 74, pp.1234~1239 (2021)
15. Won Sohn, "Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease", Clinical and Molecular Hepatology, 28(4), pp.851~863 (2022), 대한간학회
16. Moon AM, "No association between screening for hepatocellular carcinoma and reduced cancer-related mortality in patients with cirrhosis", Gastroenterology, 155, pp.1128~1139 (2018)
17. Singal AG, "Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial : where did surveillance fail?", Am J Gastroenterol, 108, pp.425~432 (2013)
18. Poustchi H, "Feasibility of conducting a randomized control trial for liver cancer screening : is a randomized controlled trial for liver cancer screening feasible or still needed?", Hepatology, 54, pp.1998~2004 (2011)
19. Woolen SA, "Patient preferences for hepatocellular carcinoma surveillance parameters", Clin Gastroenterol Hepatol, 20, pp.204~215 (2022)
20. Jung Hwan Yu, "The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection", Clinical and Molecular Hepatology, 28(3), pp.351~361 (2022), 대한간학회[DOI]
21. 심주현, "Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?", Clinical and Molecular Hepatology, 26(2), pp.183~184 (2020), 대한간학회[DOI]
22. Jer-Wei Wu, "Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma", Clinical and Molecular Hepatology, 27(4), pp.524~534 (2021), 대한간학회[DOI]
23. Lilian Yan Liang, "Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B", Clinical and Molecular Hepatology, 27(3), pp.499~509 (2021), 대한간학회[DOI]
24. Lockart I, "HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis : a meta-analysis", Hepatology, 76, pp.139~154 (2022)
25. Orci LA, "Incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease : a systematic review, meta-analysis, and meta-regression", Clin Gastroenterol Hepatol, 20, pp.283~292 (2022)
26. Kim HY, "An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B", J Hepatol, 76, pp.311~318 (2022)
27. Mi Young Jeon, "Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B", Clinical and Molecular Hepatology, 27(2), pp.295~304 (2021), 대한간학회[DOI]
28. Jamak Modaresi Esfeh, "Sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to explant pathology as the gold standard", Clinical and Molecular Hepatology, 26(1), pp.54~59 (2020), 대한간학회
29. Yoon JH, "A comparison of biannual two-phase low-dose liver CT and US for HCC surveillance in a group at high risk of HCC development", Liver Cancer, 9, pp.503~517 (2020)
30. Chan MV, "Noncontrast MRI for hepatocellular carcinoma detection : a systematic review and meta-analysis-a potential surveillance tool?", Clin Gastroenterol Hepatol, 20, pp.44~56 (2022)[DOI]
31. Kim HL, "Magnetic resonance imaging is cost-effective for hepatocellular carcinoma surveillance in high-risk patients with cirrhosis", Hepatology, 69, pp.1599~1613 (2019)
32. Singal AG, "HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis : a meta-analysis", J Hepatol, 77, pp.128~139 (2022)

관련 논문AI추천